ALLMedicine™ Helicobacter Pylori Infection Center
Research & Reviews 2,040 results
https://www.mdedge.com/hematology-oncology/article/255637/gastrointestinal-cancer/gastric-cancer-epstein-barr-virus-and-h
Jun 22nd, 2022 - Key clinical point: Epstein-Barr virus (EBV) and Helicobacter pylori coinfection is not an independent prognostic factor for gastric cancer. EBV infection was associated with survival, but not in patients with non-gastric carcinoma with lymphoid s.
https://doi.org/10.1007/s00535-022-01885-5 10.1056/NEJMoa001999 10.1111/hel.12415 10.3389/fped.2021.697200 10.1007/BF01887370 10.1017/S095026881800208X 10.1111/cas.12829 10.2183/pjab.87.405 10.1007/s10120-012-0141-x 10.1007/s10120-016-0658-5 10.1159/000477239 10.1038/s41598-020-60703-1 10.1155/2017/1286198 10.1055/s-0028-1098086 10.1111/den.13676 10.1111/hel.12597 10.1111/cas.14586 10.1002/ijc.29705 10.1111/j.1572-0241.1999.01283.x 10.1111/j.1440-1746.2007.05107.x 10.1038/s41598-017-15490-7 10.1111/j.1349-7006.2003.tb01375.x 10.1007/s00535-017-1407-1 10.1111/hel.12101
Journal of Gastroenterology; Ito M, Sugiyama A et. al.
Jun 21st, 2022 - The current status of Helicobacter pylori infection in Japan has not been investigated. We evaluated the status of H. pylori infection in a Japanese general population using large-scale resident-register-based sampling. All 6069 adults in a rural ...
https://doi.org/10.1111/hel.12911
Helicobacter Ma J, Yu M et. al.
Jun 17th, 2022 - Helicobacter pylori (H. pylori) infection and its related diseases are substantial public health burden for highly infected areas. Recently, a novel family-based H. pylori infection control and management (FBCM) strategy is introduced for H. pylor...
https://doi.org/10.1111/hel.12910
Helicobacter Souissi S, Makni C et. al.
Jun 14th, 2022 - Helicobacter pylori infection is strongly associated with chronic gastritis and is probably the main course of chronic inflammation in the gastric mucosa. Gradually, H. pylori gastritis will result in gastric atrophy and intestinal metaplasia. Ide...
https://doi.org/10.1186/s12876-022-02368-w 10.1093/ajcp/aqy019 10.1038/s41379-019-0338-1 10.1111/j.1440-1827.2007.02134.x 10.1097/PAS.0000000000001861 10.1007/s00535-021-01813-z 10.1007/s10120-021-01208-2 10.1038/s41598-021-86893-w 10.1007/s10120-011-0041-5 10.1007/s10120-011-0040-6 10.1016/j.humpath.2014.08.016 10.2169/internalmedicine.52.0361 10.1007/s12328-016-0680-5 10.12998/wjcc.v7.i13.1696 10.1097/PAS.0b013e31825033e7 10.1111/j.1443-1661.2011.01125.x 10.1111/his.12859 10.3748/wjg.v22.i48.10523 10.1016/j.gie.2017.10.016 10.1128/CMR.00011-10 10.1111/den.12676 10.1097/MD.0000000000028469 10.1097/MD.0000000000020361 10.1186/s13000-020-01047-2 10.1111/den.12212 10.1097/PAS.0b013e3181d94d53 10.1055/s-0034-1364955 10.1007/s00428-015-1753-4
BMC Gastroenterology; Iwamuro M, Kusumoto C et. al.
Jun 13th, 2022 - The endoscopic features of oxyntic gland adenoma and gastric adenocarcinoma of the fundic gland type have not been fully investigated in relation to Helicobacter pylori infection status. We compared the morphology, color, and location of these les...
Guidelines 8 results
https://doi.org/10.1111/nmo.14238
Neurogastroenterology and Motility : the Official Journal... Wauters L, Dickman R et. al.
Sep 30th, 2021 - Functional dyspepsia (FD) is one of the most common conditions in clinical practice. In spite of its prevalence, FD is associated with major uncertainties in terms of its definition, underlying pathophysiology, diagnosis, treatment, and prognosis....
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740554
Gastroenterology Shah SC, Piazuelo MB et. al.
Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281326
Gastroenterology Shah SC, Iyer PG et. al.
Feb 2nd, 2021 - The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of Helicobacter pylori after an initial attempt at eradication therapy fails, including best practice advice on specific regimen selection, and consider...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709778
Gut Banks M, Graham D et. al.
Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...
https://doi.org/10.1097/MPG.0000000000001594
Journal of Pediatric Gastroenterology and Nutrition; Jones NL, Koletzko S et. al.
May 26th, 2017 - Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediat...
Drugs 62 results see all →
Clinicaltrials.gov 176 results
https://clinicaltrials.gov/ct2/show/NCT05399862
Jun 1st, 2022 - The prime discovery of Helicobacter pylori (H. pylori) in chronic gastritis patients by Marshall and Warren in 1982 has geared a frenetic pace in H. pylori research. H. pylori is a helix-shaped microaerophilic gram negative bacterium colonising ga...
https://clinicaltrials.gov/ct2/show/NCT05121025
May 24th, 2022 - Helicobacter pylori colonizes the stomach of about half of the world's population, including about 20-30% of adults in Germany. In some cases, this colonization can lead to chronic inflammation of the gastric mucosa, which can lead to various seri...
https://clinicaltrials.gov/ct2/show/NCT05332444
May 19th, 2022 - This prospective multicenter randomized comparative study will be conducted at the National Taiwan University Hospital, NTUH Bei-Hu Branch, NTUH Hsin-Chu Branch, Taipei City Hospital Renai Branch, Buddhist Tzu Chi General Hospital, and Mennonite C...
https://clinicaltrials.gov/ct2/show/NCT05371249
May 12th, 2022 - Helicobacter pylori infection is a well-established risk factor for peptic ulcer disease and gastric cancer. It's now a consensus of experts that H.pylori infection should be treated once it is recognized. Extended proton pump inhibitor (PPI)-base...
https://clinicaltrials.gov/ct2/show/NCT04522752
May 9th, 2022 - Benign epithelial gastric polyps are benign raised lesions that originate from the gastric mucosa or submucosa and protrude from the gastric cavity with a wide base or a pedicle.The diagnosis and treatment of benign epithelial gastric polyps are c...
News 141 results
https://www.mdedge.com/hematology-oncology/article/255637/gastrointestinal-cancer/gastric-cancer-epstein-barr-virus-and-h
Jun 22nd, 2022 - Key clinical point: Epstein-Barr virus (EBV) and Helicobacter pylori coinfection is not an independent prognostic factor for gastric cancer. EBV infection was associated with survival, but not in patients with non-gastric carcinoma with lymphoid s.
https://www.mdedge.com/hematology-oncology/article/255104/gastrointestinal-cancer/commentary-gastric-cancer-chemotherapy
Nataliya Uboha, MD, PhD
Jun 1st, 2022 - Dr. Nataliya Uboha, MD Chemotherapy plays a critical role in the management of patients with advanced gastroesophageal adenocarcinoma, and a fluoropyrimidine and platinum doublet (either oxaliplatin or cisplatin) is the standard regimen used.
https://www.medscape.com/viewarticle/973403
May 4th, 2022 - The US Food and Drug Administration (FDA) has approved two vonoprazan-based treatments for Helicobacter pylori infection: Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak (vonoprazan, amoxicillin), both from Phat...
https://www.medscape.com/viewarticle/968400
Feb 14th, 2022 - NEW YORK (Reuters Health) - The prevalence of Helicobacter pylori infection in children and adolescents decreased by more than half over the past 30 years but the infections remain prevalent globally, particularly in low- and middle-income countri...
https://www.medscape.com/viewarticle/962697
Nov 10th, 2021 - A novel noninvasive endoscopy trial lends further support for the safety of single antiplatelet therapy after a 6-month course of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI). Results from the OP...